CD274 and neoplasm: Indeed, TNBC is a more immunogenic molecular subtype, containing higher levels of stromal tumor-infiltrating lymphocytes (TILs) and programmed cell death ligand 1 (PD-L1) expression, which suggests a greater immunogenic potential [3–5].